Publication
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141.
Journal Paper/Review - Mar 4, 2022
Gillison Maura L, Blumenschein George, Fayette Jerome, Guigay Joel, Colevas A Dimitrios, Licitra Lisa, Harrington Kevin J, Kasper Stefan, Vokes Everett, Even Caroline, Worden Francis, Saba Nabil F, Iglesias Docampo Lara Carmen, Haddad Robert, Rordorf Tamara, Kiyota Naomi, Tahara Makoto, Jayaprakash Vijayvel, Weibel Lisa, Ferris Robert L
Gillison, Maura L
4
0
Blumenschein, George
4
0
Fayette, Jerome
4
0
Guigay, Joel
4
0
Colevas, A Dimitrios
4
0
Licitra, Lisa
9
0
Harrington, Kevin J
8
0
Kasper, Stefan
5
0
Vokes, Everett
5
0
Even, Caroline
4
0
Worden, Francis
4
0
Saba, Nabil F
4
0
Iglesias Docampo, Lara Carmen
3
0
Haddad, Robert
4
0
Rordorf, Tamara
34
1
Kiyota, Naomi
4
0
Tahara, Makoto
10
0
Jayaprakash, Vijayvel
2
0
Weibel, Lisa
4
0
Ferris, Robert L
4
0